These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33548022)

  • 21. Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort.
    Pernod G; Bosson JL; Golshayan D; Barro C; Forneris G; Martina G; Bonfant G; Hurot JM; Turc-Baron C; Jouet C; Theytaz J; Jeantet A; Wauters JP; Cordonnier D;
    Kidney Int; 2006 Apr; 69(8):1424-30. PubMed ID: 16557227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS).
    Matsubara Y; Kimachi M; Fukuma S; Onishi Y; Fukuhara S
    PLoS One; 2017; 12(3):e0173468. PubMed ID: 28273175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk factors in children on dialysis: an update.
    Querfeld U; Schaefer F
    Pediatr Nephrol; 2020 Jan; 35(1):41-57. PubMed ID: 30382333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.
    Levin A; Djurdjev O; Barrett B; Burgess E; Carlisle E; Ethier J; Jindal K; Mendelssohn D; Tobe S; Singer J; Thompson C
    Am J Kidney Dis; 2001 Dec; 38(6):1398-407. PubMed ID: 11728982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
    Chen T; Yang M
    Int Immunopharmacol; 2020 Jan; 78():106063. PubMed ID: 31835088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess protein intake relative to fiber and cardiovascular events in elderly men with chronic kidney disease.
    Xu H; Rossi M; Campbell KL; Sencion GL; Ärnlöv J; Cederholm T; Sjögren P; Risérus U; Lindholm B; Carrero JJ
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):597-602. PubMed ID: 27089977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: A community-based prospective study (Ansung-Ansan cohort 2001-12).
    Bae JC; Cho NH; Suh S; Kim JH; Hur KY; Jin SM; Lee MK
    J Diabetes; 2015 Nov; 7(6):791-9. PubMed ID: 25407754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients.
    Shoji T; Marubayashi S; Shigematsu T; Iseki K; Tsubakihara Y; ;
    Ther Apher Dial; 2015 Jun; 19(3):235-44. PubMed ID: 25530222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk prediction in chronic kidney disease patients.
    Cedeño Mora S; Goicoechea M; Torres E; Verdalles Ú; Pérez de José A; Verde E; García de Vinuesa S; Luño J
    Nefrologia; 2017; 37(3):293-300. PubMed ID: 28495396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
    Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
    Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
    Tatami Y; Yasuda Y; Suzuki S; Ishii H; Sawai A; Shibata Y; Ota T; Shibata K; Niwa M; Morimoto R; Hayashi M; Kato S; Maruyama S; Murohara T
    Atherosclerosis; 2015 Dec; 243(2):349-55. PubMed ID: 26519631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy.
    Tada H; Nomura A; Yoshimura K; Itoh H; Komuro I; Yamagishi M; Takamura M; Kawashiri MA
    Circ J; 2020 Feb; 84(3):509-515. PubMed ID: 32023582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.